- Report
- October 2024
- 70 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
North America
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Europe
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Japan
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United States
From €907EUR$950USD£760GBP
- Report
- February 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
The Facial Injectible market is a subset of the Medical Devices industry, focusing on products used to improve the appearance of the face. These products are typically used to reduce wrinkles, fill in hollows, and add volume to the face. Common facial injectibles include dermal fillers, neuromodulators, and fat grafting. Dermal fillers are used to fill in wrinkles and add volume to the face, while neuromodulators are used to relax facial muscles and reduce wrinkles. Fat grafting is a procedure that involves transferring fat from one area of the body to the face to add volume.
Some companies in the Facial Injectible market include Allergan, Galderma, Merz, and Revance. Allergan is a global pharmaceutical company that produces a range of facial injectibles, including dermal fillers and neuromodulators. Galderma is a Swiss-based pharmaceutical company that produces a range of facial injectibles, including dermal fillers and neuromodulators. Merz is a German-based pharmaceutical company that produces a range of facial injectibles, including dermal fillers and neuromodulators. Revance is a US-based biotechnology company that produces a range of facial injectibles, including dermal fillers and neuromodulators. Show Less Read more